Rhumbline Advisers ARRIVENT BIOPHARMA INC Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024
Number of Shares
33,621
Previous 12,707 164.59%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
N/A
20,914 Added 164.59%
33,621 $0
Q2 2024

Aug 01, 2024
BUY
N/A
2,942 Added 30.13%
12,707 $0
Q1 2024

May 09, 2024
BUY
N/A
9,765 New
9,765 $0
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email